4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lifecore Biomedical, Inc. (LFCR) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chaska, United States with about 382 employees. Its market capitalization is roughly $176 million. In the fiscal year ended 2025-05-31, LFCR reported $129M in revenue and ($39M) in net income.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Interactive charts & full statements → Open the LFCR valuation workbench →
| Income statement | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Total Revenue | $129M | $128M | $103M | $111M |
| Gross Profit | $40M | $42M | $28M | $39M |
| Operating Income (EBIT) | ($12M) | ($7M) | ($20M) | ($3M) |
| Net Income | ($39M) | $12M | ($100M) | ($117M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-09-30 | 2025-05-31 | 2025-02-28 | 2024-11-30 |
|---|---|---|---|---|---|
| Total Revenue | $23M | $31M | $36M | $35M | $33M |
| Gross Profit | $4M | $8M | $14M | $10M | $11M |
| Operating Income (EBIT) | ($5M) | ($3M) | $3M | ($2M) | ($2M) |
| Net Income | ($15M) | ($10M) | ($1M) | ($15M) | ($7M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Total Assets | $232M | $239M | $254M | $254M | — |
| Total Liabilities | $246M | $238M | $243M | $258M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LFCR viewer.
About TickerBase · Data methodology & sources